A detailed history of Y Intercept (Hong Kong) LTD transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 28,230 shares of BMRN stock, worth $1.88 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
28,230
Holding current value
$1.88 Million
% of portfolio
0.13%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$69.02 - $93.84 $1.95 Million - $2.65 Million
28,230 New
28,230 $1.98 Million
Q2 2023

Aug 14, 2023

BUY
$86.68 - $100.3 $813,405 - $941,215
9,384 New
9,384 $813,000
Q4 2022

Feb 14, 2023

BUY
$80.93 - $108.63 $826,538 - $1.11 Million
10,213 Added 224.17%
14,769 $1.53 Million
Q3 2022

Feb 14, 2023

BUY
$82.16 - $96.94 $374,320 - $441,658
4,556 New
4,556 $386,000
Q2 2022

Aug 08, 2022

SELL
$71.48 - $86.85 $463,690 - $563,395
-6,487 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$74.28 - $92.69 $272,161 - $339,616
3,664 Added 129.79%
6,487 $500,000
Q4 2021

Feb 14, 2022

BUY
$71.72 - $91.47 $202,465 - $258,219
2,823 New
2,823 $249,000
Q3 2021

Nov 15, 2021

SELL
$74.77 - $85.47 $1.61 Million - $1.84 Million
-21,479 Closed
0 $0
Q2 2021

Aug 26, 2021

BUY
$75.51 - $84.79 $1.62 Million - $1.82 Million
21,479 New
21,479 $1.79 Million
Q2 2021

Aug 12, 2021

BUY
$75.51 - $84.79 $0 - $0
0 New
0 $1.79 Million
Q1 2021

May 12, 2021

SELL
$74.73 - $90.69 $381,347 - $462,791
-5,103 Closed
0 $0
Q4 2020

Feb 05, 2021

BUY
$72.61 - $90.2 $370,528 - $460,290
5,103 New
5,103 $444,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Y Intercept (Hong Kong) LTD Portfolio

Follow Y Intercept (Hong Kong) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.